Trinity Biotech PLC
TRIB· Nasdaq
Trinity Biotech PLC
- Last sale
- Oct 2, 2026 · -12.32%
- Market cap
- $99.16M
- 18.71M shares
- Filings
- 500
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $61,555,000 | reported | |
| FY 2023 | 2023-12-31 | $56,832,000 | reported | |
| FY 2022 | 2022-12-31 | $62,521,000 revised | reported | |
| FY 2021 | 2021-12-31 | $81,149,000 revised | reported | |
| FY 2020 | 2020-12-31 | $101,980,000 | reported | |
| FY 2019 | 2019-12-31 | $90,435,000 | reported | |
| FY 2018 | 2018-12-31 | $97,035,000 | reported | |
| FY 2017 | 2017-12-31 | $99,140,000 | reported | |
| FY 2016 | 2016-12-31 | $99,611,000 | reported | |
| FY 2015 | 2015-12-31 | $100,195,000 | reported |
Trinity Biotech PLC · CIK 888721 · Engraved from SEC EDGAR
